• Video
  • Shop
  • Culture
  • Family
  • Wellness
  • Food
  • Living
  • Style
  • Travel
  • News
  • Book Club
  • Newsletter
  • Privacy Policy
  • Your US State Privacy Rights
  • Children's Online Privacy Policy
  • Interest-Based Ads
  • Terms of Use
  • Your Privacy Choices
  • Contact Us
  • Recalls and Product Safety Alerts
  • © 2026 ABC News
  • Wellness

Alzheimer's Advances: Promising But Slow-Going

ByLARA SALAHI
October 21, 2010, 9:17 PM

Oct. 22, 2010— -- It's been nearly a decade since the FDA approved a new treatment for Alzheimer's disease patients. Like much of disease research, many early studies show some promise -- but researchers say finding advances in prevention and treatment for Alzheimer's has been just as slow as the progression of the disease itself.

"It's problematic," said Dr. Gary Small, director of the Center on Aging at the University of California-Los Angeles. "We have no disease-modifying treatments."

CLICK HERE to visit ABCNews.com's OnCall+ Alzheimer's resource section.

The FDA has only approved two types of medication to improve cognitive symptoms of Alzheimer's disease such as memory loss, according to the Alzheimer's Association. But there is no treatment that stops or reverses its progression.

The problem could lay in not enough study participants and not enough funding for clinical trials, according to the Alzheimer's Association.

About $6 billion of funding is funneled to cancer research, and $4 billion is spent on heart disease research. Only $500 million has been allocated to Alzheimer's research, according to the Alzheimer's Association.

According to some experts, the problem lies, in part, with researchers not able to identify which mechanisms in the brain to target when studying potential treatments.

"When we examine the brains of [Alzheimer's disease] patients, there are many changes and we are not sure which changes are the earliest and most important," said Dr. Richard Lipton, neurologist at Montefiore Medical Center and professor of neurology at Albert Einstein College of Medicine.

Most research has banked on targeting beta-amyloid plaques, which build up in the brain as the disease progresses.

"I think there's been an overemphasis [in research] on amyloid but we're not seeing any results on this work," said Small.

In fact, Small said tau protein tangles, which also build up in the brain of Alzheimer's patients, also may serve as an important key to treatment research. So, too, is the possibility that inflammation in the brain can trigger the disease.

"It's complicated," said Small. "And to do these studies and really know, we have to be focused on only one mechanism at a time."

Up Next in Wellness—

Doctor and TV host, 59, slams 'double standard' after announcing pregnancy

November 17, 2026

What parents need to know as US loses measles elimination status

November 17, 2026

ABC News' Gio Benitez reveals heart health scare at 41

November 17, 2026

Cancer society issues most specific prostate cancer screening guidelines yet

November 12, 2026

Shop GMA Favorites

ABC will receive a commission for purchases made through these links.

Sponsored Content by Taboola

The latest lifestyle and entertainment news and inspiration for how to live your best life - all from Good Morning America.
  • Contests
  • Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Children’s Online Privacy Policy
  • Advertise with us
  • Your US State Privacy Rights
  • Interest-Based Ads
  • About Nielsen Measurement
  • Press
  • Feedback
  • Shop FAQs
  • ABC News
  • ABC
  • All Videos
  • All Topics
  • Sitemap
  • Recalls and Product Safety Alerts

© 2026 ABC News
  • Privacy Policy— 
  • Your US State Privacy Rights— 
  • Children's Online Privacy Policy— 
  • Interest-Based Ads— 
  • Terms of Use— 
  • Your Privacy Choices— 
  • Contact Us— 
  • Recalls and Product Safety Alerts— 

© 2026 ABC News